Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Breast cancer risk after supradiaphragmatic radiotherapy for Hodgkin's lymphoma in England and Wales: a National Cohort Study.

Swerdlow AJ, Cooke R, Bates A, Cunningham D, Falk SJ, Gilson D, Hancock BW, Harris SJ, Horwich A, Hoskin PJ, Linch DC, Lister TA, Lucraft HH, Radford JA, Stevens AM, Syndikus I, Williams MV.

J Clin Oncol. 2012 Aug 1;30(22):2745-52. doi: 10.1200/JCO.2011.38.8835. Epub 2012 Jun 25.

PMID:
22734026
2.

Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.

De Bruin ML, Sparidans J, van't Veer MB, Noordijk EM, Louwman MW, Zijlstra JM, van den Berg H, Russell NS, Broeks A, Baaijens MH, Aleman BM, van Leeuwen FE.

J Clin Oncol. 2009 Sep 10;27(26):4239-46. doi: 10.1200/JCO.2008.19.9174. Epub 2009 Aug 10.

PMID:
19667275
3.

Breast cancer after treatment of Hodgkin's disease.

Hancock SL, Tucker MA, Hoppe RT.

J Natl Cancer Inst. 1993 Jan 6;85(1):25-31.

PMID:
8416252
4.

High risk of breast carcinoma after irradiation of young women with Hodgkin's disease.

Aisenberg AC, Finkelstein DM, Doppke KP, Koerner FC, Boivin JF, Willett CG.

Cancer. 1997 Mar 15;79(6):1203-10.

PMID:
9070499
5.

Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.

Travis LB, Hill D, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, Glimelius B, Andersson M, Pukkala E, Lynch CF, Pee D, Smith SA, Van't Veer MB, Joensuu T, Storm H, Stovall M, Boice JD Jr, Gilbert E, Gail MH.

J Natl Cancer Inst. 2005 Oct 5;97(19):1428-37.

PMID:
16204692
6.

Risk of breast cancer and breast cancer characteristics in women treated with supradiaphragmatic radiation for Hodgkin lymphoma: Mayo Clinic experience.

Wahner-Roedler DL, Nelson DF, Croghan IT, Achenbach SJ, Crowson CS, Hartmann LC, O'Fallon WM.

Mayo Clin Proc. 2003 Jun;78(6):708-15.

PMID:
12934780
7.

Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors.

Cooke R, Jones ME, Cunningham D, Falk SJ, Gilson D, Hancock BW, Harris SJ, Horwich A, Hoskin PJ, Illidge T, Linch DC, Lister TA, Lucraft HH, Radford JA, Stevens AM, Syndikus I, Williams MV; England and Wales Hodgkin Lymphoma Follow-up Group, Swerdlow AJ.

Br J Cancer. 2013 Jun 11;108(11):2399-406. doi: 10.1038/bjc.2013.219. Epub 2013 May 7.

8.

[Bilateral breast cancer after Hodgkin disease. Clinical and pathological characteristics and therapeutic possibilities: an analysis of 13 cases].

Cutuli B, de La Rochefordière A, Dhermain F, Borel C, Graic Y, de Lafontan B, Dilhyudy JM, Mignotte H, Tessier E, Tortochaux J, N'Guyen T, Bey P, Le Mevel-Le Pourhier A, Arriagada R.

Cancer Radiother. 1997;1(4):300-6. Review. French.

PMID:
9435820
9.

Incidence of second solid cancer in patients after treatment of Hodgkin's disease.

Glanzmann C, Veraguth A, Lütolf UM.

Strahlenther Onkol. 1994 Mar;170(3):140-6.

PMID:
8160093
10.

Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option.

Haberer S, Belin L, Le Scodan R, Kirova YM, Savignoni A, Stevens D, Moisson P, Decaudin D, Pierga JY, Reyal F, Campana F, Fourquet A, Bollet MA.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):e145-52. doi: 10.1016/j.ijrobp.2011.03.013. Epub 2011 May 24.

PMID:
21605948
11.

Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease.

van Leeuwen FE, Klokman WJ, Stovall M, Hagenbeek A, van den Belt-Dusebout AW, Noyon R, Boice JD Jr, Burgers JM, Somers R.

J Natl Cancer Inst. 1995 Oct 18;87(20):1530-7.

PMID:
7563187
12.

Malignant breast tumors after radiotherapy for a first cancer during childhood.

Guibout C, Adjadj E, Rubino C, Shamsaldin A, Grimaud E, Hawkins M, Mathieu MC, Oberlin O, Zucker JM, Panis X, Lagrange JL, Daly-Schveitzer N, Chavaudra J, de Vathaire F.

J Clin Oncol. 2005 Jan 1;23(1):197-204.

PMID:
15625374
13.
14.

Breast cancer and other second neoplasms after childhood Hodgkin's disease.

Bhatia S, Robison LL, Oberlin O, Greenberg M, Bunin G, Fossati-Bellani F, Meadows AT.

N Engl J Med. 1996 Mar 21;334(12):745-51.

15.

Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.

Schaapveld M, Aleman BM, van Eggermond AM, Janus CP, Krol AD, van der Maazen RW, Roesink J, Raemaekers JM, de Boer JP, Zijlstra JM, van Imhoff GW, Petersen EJ, Poortmans PM, Beijert M, Lybeert ML, Mulder I, Visser O, Louwman MW, Krul IM, Lugtenburg PJ, van Leeuwen FE.

N Engl J Med. 2015 Dec 24;373(26):2499-511. doi: 10.1056/NEJMoa1505949.

16.

Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease.

van Leeuwen FE, Klokman WJ, Stovall M, Dahler EC, van't Veer MB, Noordijk EM, Crommelin MA, Aleman BM, Broeks A, Gospodarowicz M, Travis LB, Russell NS.

J Natl Cancer Inst. 2003 Jul 2;95(13):971-80.

PMID:
12837833
17.

Increased risk of breast cancer in splenectomized patients undergoing radiation therapy for Hodgkin's disease.

Chung CT, Bogart JA, Adams JF, Sagerman RH, Numann PJ, Tassiopoulos A, Duggan DB.

Int J Radiat Oncol Biol Phys. 1997 Jan 15;37(2):405-9.

PMID:
9069314
18.

Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome.

Mauch PM, Kalish LA, Marcus KC, Coleman CN, Shulman LN, Krill E, Come S, Silver B, Canellos GP, Tarbell NJ.

Blood. 1996 May 1;87(9):3625-32.

19.

Does radiotherapy around the time of pregnancy for Hodgkin's disease modify the risk of breast cancer?

Chen J, Lee RJ, Tsodikov A, Smith L, Gaffney DK.

Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1474-9.

PMID:
15050326
20.

Calculated risk of breast cancer following mantle irradiation determined by measured dose.

Janjan NA, Zellmer DL.

Cancer Detect Prev. 1992;16(5-6):273-82.

PMID:
1473117

Supplemental Content

Support Center